Algiecel A/S

Public limited companyCVR 42394416Odense MActive

Algiecel A/S is a public limited company, based in Odense M, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 16.7m. With 18 employees, the company is about 4 times larger than the industry median. Equity fell to DKK 29.2m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 10.8m−280.6% vs. 2024
Net profit−DKK 16.7m−39% vs. 2024
EquityDKK 29.2m−36.4% vs. 2024
Employees18latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 12m to DKK 16.7m (2024 → 2025).
  • Equity fell 36% (2024 → 2025), to DKK 29.2m.

Employees

  • 1 fewer employees than a year earlier: 18 (07/2026) against 19 (07/2025).

Management and owners, last 24 months

  • New in management: Susanne Palsten Buchardt (ceo, 10/04/2025), Henrik Busch-Larsen (deputy chair, 16/05/2025) and Tove Feld (chair of the board, 16/06/2026).
  • Stepped down: Henrik Busch-Larsen (director, 10/04/2025), Henrik Busch-Larsen (board member, 15/05/2025) and Tina Moe (chair of the board, 16/06/2026).
  • New owners registered: Hbl Invest ApS (31/10/2024).
  • No longer registered as owner: Hbl Invest ApS (30/10/2024).

Registrations, last 24 months

  • 30/07/2026: Share capital changed from 1,606,514 DKK to 1,611,552 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 31/10/2024: Share capital changed from 1,499,174 DKK to 1,606,514 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m20212022202320242025
EquityNet profit
Financial figures for Algiecel A/S
20212022202320242025Change
Revenuenot statednot statednot statednot statednot stated–
Gross profit−1,331−6,189−3,490−2,835−10,789−280.6%
Operating profit (EBIT)––––−22,613–
Profit before tax−1,726−9,166−11,511−13,746−22,469−63.5%
Net profit−1,283−6,697−11,089−12,002−16,686−39%
Total assets1,4845,6455,70049,65331,985−35.6%
Equity217−1,380−7,12845,89529,210−36.4%
Liabilities1,2677,02512,8273,7582,775−26.1%
Cash and cash equivalents3102,8543,56346,20524,451−47.1%
Average number of employees1481213+8.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 5 years in a row

    Net result has been negative in 2021–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 36% from 2024 to 2025 (DKK 45.9m to DKK 29.2m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

5 financial years
Annual reports for Algiecel A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202524/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202428/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202331/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202204/05/2023The companyPDFXBRL
202117/05/2021 – 31/12/202130/05/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202508/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 10.8mNo. 392 of 421
Better than 7% of the companies in the industry
EquityDKK 29.2mNo. 86 of 431
Better than 80% of the companies in the industry
Number of employees18No. 121 of 431
Better than 72% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,650of 69,742
Better than 0%
No. 4,549of 69,964
Better than 93%
Same industry and fewer than 20 employees329 companies in the comparison
No. 308of 323
Better than 5%
No. 30of 329
Better than 91%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,506of 33,588
Better than 0%
No. 1,773of 33,687
Better than 95%
All companies of type A/S18,025 companies in the comparison
No. 17,697of 17,786
Better than 1%
No. 4,993of 18,024
Better than 72%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Algiecel A/S−DKK 10.8m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Algiecel A/S−DKK 16.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Algiecel A/SDKK 29.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Algiecel A/S18
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Algiecel A/S

Management

6 active registrations

Executive management

Executive management at Algiecel A/S
NameRoleAppointed
Susanne Palsten BuchardtCEO10/04/2025

Board of directors

Board of directors at Algiecel A/S
NameRoleAppointed
Jeppe HøierBoard member30/07/2021
Martin LavesenBoard member09/01/2023
Merete Lundbye MøllerBoard member02/05/2023
Henrik Busch-LarsenDeputy chair16/05/2025
Tove FeldChair of the board16/06/2026
Founders
Manila Invest ApS
Former management (5)
Former management at Algiecel A/S
NameRoleAppointedResigned
Martin LavesenDirector17/05/202130/06/2021
Martin LavesenChair of the board30/06/202108/01/2023
Henrik Busch-LarsenDirector30/06/202110/04/2025
Henrik Busch-LarsenBoard member30/06/202115/05/2025
Tina MoeChair of the board09/01/202316/06/2026

Signing rule: Selskabet tegnes af en direktør, af en direktør og bestyrelsesformanden i forening, eller af den samlede bestyrelse.

Address and production units

2 active production units

Hunderupvej 89
5230 Odense M

Odense Municipality · Postcode 5230

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
Algiecel PilotGregersensvej 1, 2630 Taastrup171030017419
Algiecel A/SHunderupvej 89, 5230 Odense M11027170907

Purpose

Selskabets formål er forskning, udvikling, produktion, fabrikation, handel og andet i forbindelse hermed beslægtet virksomhed efter selskabets skøn.

The purpose is quoted from the register in Danish.

Changes year by year

62 registered events
20264 changescapital 1 · accounts 1 · management 2
  • Share capital changed from 1,606,514 DKK to 1,611,552 DKK
  • Annual report for 2025 published
  • Tove Feld appointed chair of the board
  • Tina Moe stepped down as chair of the board
20256 changesaccounts 1 · management 4 · industry 1
  • Annual report for 2024 published
  • Henrik Busch-Larsen appointed deputy chair
  • Henrik Busch-Larsen stepped down as board member
  • Susanne Palsten Buchardt appointed ceo
  • Henrik Busch-Larsen stepped down as director
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202417 changescapital 4 · ownership 9 · name 1 · address 2 · accounts 1
  • Share capital changed from 1,499,174 DKK to 1,606,514 DKK
  • HBL INVEST ApS registered as owner (33.33%)
  • HBL INVEST ApS is no longer registered as owner
  • Share capital changed from 1,472,735 DKK to 1,499,174 DKK
  • Name changed from Algiecel ApS to Algiecel A/S
  • Share capital changed from 1,011,946 DKK to 1,472,735 DKK
  • AURELIUS LIMITED registered as owner (5%)
  • Danmarks Eksport- og Investeringsfond registered as owner (5%)
  • HBL INVEST ApS registered as owner (66.67%)
  • MANILA INVEST ApS is no longer registered as owner
  • AURELIUS LIMITED is no longer registered as owner
  • HBL INVEST ApS is no longer registered as owner
  • Moved to Hunderupvej 89, 5230 Odense M
  • Annual report for 2023 published
  • Share capital changed from 961,946 DKK to 1,011,946 DKK
  • E4I Impact ApS is no longer registered as owner
  • Moved to Helgavej 26, 5230 Odense M
20239 changescapital 2 · ownership 2 · accounts 1 · management 4
  • Share capital changed from 902,246 DKK to 961,946 DKK
  • AURELIUS LIMITED registered as owner (10%)
  • Man Trustee Jersey Limited as Trustee of the EW Davidson Settlement is no longer registered as owner
  • Annual report for 2022 published
  • Merete Lundbye Møller appointed board member
  • Share capital changed from 845,484 DKK to 902,246 DKK
  • Martin Lavesen appointed board member
  • Tina Moe appointed chair of the board
  • Martin Lavesen stepped down as chair of the board
20227 changescapital 2 · ownership 3 · accounts 1 · address 1
  • Share capital changed from 725,000 DKK to 845,484 DKK
  • Man Trustee Jersey Limited as Trustee of the EW Davidson Settlement registered as owner (10%)
  • Annual report for 2021 published
  • E4I Impact ApS registered as owner (5%)
  • Jeppe Høier is no longer registered as owner
  • Moved to Oslo Plads 2, 2100 København Ø
  • Share capital changed from 712,500 DKK to 725,000 DKK
202119 changescapital 3 · management 6 · ownership 9 · founded 1
  • Share capital changed from 662,500 DKK to 712,500 DKK
  • Jeppe Høier appointed board member
  • HBL INVEST ApS registered as owner (66.67%)
  • Jeppe Høier registered as owner (5%)
  • HBL INVEST ApS is no longer registered as owner
  • Share capital changed from 600,000 DKK to 662,500 DKK
  • HBL INVEST ApS registered as owner (90%)
  • MANILA INVEST ApS registered as owner (5%)
  • HBL INVEST ApS is no longer registered as owner
  • Share capital changed from 50,000 DKK to 600,000 DKK
  • Henrik Busch-Larsen appointed board member
  • Henrik Busch-Larsen appointed director
  • Martin Lavesen appointed chair of the board
  • Martin Lavesen stepped down as director
  • HBL INVEST ApS registered as owner (100%)
  • MANILA INVEST ApS is no longer registered as owner
  • Registered as Algiecel ApS
  • Martin Lavesen appointed director
  • MANILA INVEST ApS registered as owner (100%)

Related companies

Same industry in Odense

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction